Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations

Investor Relations

Stock price graph
     

Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System

Ticker Symbol: SPPI

View all »   RSSRecent Releases

Aug 17, 2015
Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Upcoming Apaziquone Phase 3 Trial in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)

Aug 6, 2015
Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
7.07
Change:
- 0.20
Day High:
7.25
Day Low:
7.01
Volume:
883,800
1:47 PM ET on Sep 1, 2015
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR